Research Roundup

Debbie Rigby rounds up the latest in research news Glucagon-like peptide-1 receptor agonists for primary cardiovascular disease prevention in type 2 diabetes Current evidence does not support a cardiovascular benefit of GLP-1 receptor agonists for primary CVD prevention. In a meta-analysis of 11 cardiovascular outcome trials involving 77,419 participants with T2D and no prior CVD,